Page last updated: 2024-08-21

indazoles and Cancer of Pituitary

indazoles has been researched along with Cancer of Pituitary in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (66.67)24.3611
2020's1 (33.33)2.80

Authors

AuthorsStudies
Bray, D; Garzon-Muvdi, T; Ioachimescu, A; Maldonado, J; Mayol, M; Medina, EJ; Morales, B; Neill, S; Porto, E; Pradilla, G; Read, W; Revuelta Barbero, JM; Rodas, A; Zohdy, YM1
Bellio, M; Buratto, M; Chiara Zatelli, M; Degli Uberti, E; Di Pasquale, C; Falletta, S; Gentilin, E1
Campitiello, M; Eid, N; Hennequin, L; Longo, R; Plastino, F; Quétin, P; Wendel, C1

Reviews

1 review(s) available for indazoles and Cancer of Pituitary

ArticleYear
Therapeutic response to pazopanib: case report and literature review on molecular abnormalities of aggressive prolactinomas.
    Frontiers in endocrinology, 2023, Volume: 14

    Topics: Humans; Indazoles; Male; Middle Aged; Pituitary Neoplasms; POU Domain Factors; Prolactinoma

2023

Other Studies

2 other study(ies) available for indazoles and Cancer of Pituitary

ArticleYear
PI3K/Akt/mTOR pathway involvement in regulating growth hormone secretion in a rat pituitary adenoma cell line.
    Endocrine, 2018, Volume: 60, Issue:2

    Topics: Adenoma; Animals; Cell Line, Tumor; Everolimus; Feedback, Physiological; Growth Hormone; Imidazoles; Indazoles; Insulin-Like Growth Factor I; Phosphatidylinositol 3-Kinases; Phosphorylation; Piperazines; Pituitary Neoplasms; Proto-Oncogene Proteins c-akt; Quinolines; Rats; Signal Transduction; TOR Serine-Threonine Kinases

2018
Pituitary Metastasis from Renal Cell Carcinoma: Description of a Case Report.
    The American journal of case reports, 2017, Jan-03, Volume: 18

    Topics: Antineoplastic Combined Chemotherapy Protocols; Axitinib; Carcinoma, Renal Cell; Disease Progression; Everolimus; Humans; Imidazoles; Indazoles; Indoles; Kidney Neoplasms; Male; Middle Aged; Neoplasm Staging; Neurosurgical Procedures; Niacinamide; Phenylurea Compounds; Pituitary Neoplasms; Pyrroles; Radiotherapy, Adjuvant; Sorafenib; Sunitinib; Treatment Outcome

2017